SPRY2 and diffuse large B-cell lymphoma: found that in diffuse large B‐cell lymphoma SPRY2 promoter hypermethylation, correlated with a significant reduction in 5‐year survival, and expression of SPRY2 could inhibit B‐cell proliferation.23, 24